What Are the Top COVID Plays for 2022?

Will COVID-19 be finished in 2022? That would be nice. If the vaccines work and we develop "herd immunity," COVID will certainly recede in importance. It will be more like the flu, and many of us will get vaccinated every year to stay safe. So how should investors play this transition?

Three Fool.com contributors have three different approaches for the new year. Here's why they like Pfizer (NYSE: PFE), Novavax (NASDAQ: NVAX), and Live Nation Entertainment (NYSE: LYV) in 2022 and beyond.

Image source: Getty Images.

Continue reading

Source Fool.com